FDA Funding Level Creates Problems Beyond Staff Shortages – OND Head
This article was originally published in The Tan Sheet
Executive Summary
FDA's funding level not only limits its staffing resources, but also prevents it from starting necessary information technology upgrades and from supporting research crucial to improving the efficacy and safety of OTC and other drugs, says Office of New Drugs Direct John Jenkins, MD
You may also be interested in...
Sweeping Changes At CDER Recommended In IoM Drug Safety Report
FDA's Center for Drug Evaluation & Research is "an organization in urgent need of great change," the Institute of Medicine's Assessment of the U.S. Drug Safety System Committee concludes in a Sept. 22 final report
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.